Bristol-Myers Squibb Company
BMYAction· NYSE· USD
L'essentiel à retenir
- • Dernier cours : 61,46 $US (cours différé)
- • Variation sur 1 an : +34,4 %
- • Type d'actif : Action
- • Place de cotation : NYSE
- • Devise de cotation : USD
- • Clôture précédente : 62,40 $US
Informations
- Symbole
- BMY
- Type
- Action
- Place
- NYSE
- Devise
- USD
- Clôture veille
- 62,40 $US
- Variation 1 an
- +34,4 %
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin.
Yahoo Finance · 01/10/2026 · lire l'article ↗
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale
Johnson & Johnson's revenue base runs roughly double Bristol-Myers Squibb's, with the gap showing signs of widening over the past two years.
Yahoo Finance · 01/10/2026 · lire l'article ↗
Bristol Myers Squibb’s Dividend Sustainability Hinges on One Critical Cash Flow Metric
Bristol Myers Squibb has raised its dividend for 17 straight years, but a looming patent cliff on its biggest cash generator puts that streak on a collision course with reality in 2027.
Yahoo Finance · 30/09/2026 · lire l'article ↗
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Yahoo Finance · 30/09/2026 · lire l'article ↗
CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J
The global CAR T-cell therapy market is projected to grow from USD 7.24 billion in 2026 to USD 13.78 billion by 2031, registering a 13.7% CAGR. Growth is driven by rising cancer prevalence, technological advances, expanding clinical trials, and increased investment, while high costs and adverse effects remain barriers. Yescarta led the product market in 2025, hospitals were the largest end-user segment, and Asia Pacific is forecast to record the fastest growth through 2031.Dublin, Sept. 30, 2026
Yahoo Finance · 30/09/2026 · lire l'article ↗
How Strong Phase 3 MRD Data for ZENBEXUS in Myeloma Could Impact Bristol Myers Squibb (BMY) Investors
In September 2026, Bristol Myers Squibb reported first-time, pivotal Phase 3 EXCALIBER-RRMM data showing ZENBEXUS (iberdomide) plus daratumumab and dexamethasone produced a statistically significant, clinically meaningful improvement in minimal residual disease–negative complete responses versus a standard daratumumab-based regimen in relapsed or refractory multiple myeloma. This MRD-focused outcome is particularly important because it informs the accelerated approval pathway for ZENBEXUS...
Yahoo Finance · 30/09/2026 · lire l'article ↗
Titres et résumés fournis par les sources d'origine (flux Yahoo Finance). Cliquez pour lire l'article complet.
Questions fréquentes sur Bristol-Myers Squibb Company
- Quel est le cours actuel de Bristol-Myers Squibb Company ?
- Le dernier cours connu de Bristol-Myers Squibb Company (BMY) est de 61,46 $US (cours différé, fourni à titre informatif). Cette page est mise à jour régulièrement.
- Quelle est la performance de Bristol-Myers Squibb Company sur un an ?
- Sur les 12 derniers mois, Bristol-Myers Squibb Company (BMY) affiche une variation de +34,4 %. Les performances passées ne préjugent pas des performances futures.
- Comment suivre Bristol-Myers Squibb Company dans mon portefeuille ?
- Créez un compte gratuit sur AssetApp, ajoutez BMY à l'un de vos portefeuilles et suivez sa valeur, vos plus-values et son actualité — aux côtés de vos autres actifs.
Actifs similaires
Bristol-Myers Squibb Company : suivre cet actif
Bristol-Myers Squibb Company (BMY) est une action coté sur NYSE en USD. Avec AssetApp, ajoutez BMY à votre portefeuille pour suivre sa valeur, vos gains latents et réalisés, et l'évolution de votre patrimoine — sans dépendre de votre courtier.
Suivre BMY gratuitement